Montana’s plan to become an experimental medical hub just pushed forward

As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers.

Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval.

Once its treatment is rubber-stamped, the…